Glatz, T.; Verst, R.; Kuvendjiska, J.; Bronsert, P.; Becker, H.; Hoeppner, J.; Kulemann, B.
Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials. J. Clin. Med. 2020, 9, 2654.
https://doi.org/10.3390/jcm9082654
AMA Style
Glatz T, Verst R, Kuvendjiska J, Bronsert P, Becker H, Hoeppner J, Kulemann B.
Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials. Journal of Clinical Medicine. 2020; 9(8):2654.
https://doi.org/10.3390/jcm9082654
Chicago/Turabian Style
Glatz, Torben, Rasmus Verst, Jasmina Kuvendjiska, Peter Bronsert, Heiko Becker, Jens Hoeppner, and Birte Kulemann.
2020. "Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials" Journal of Clinical Medicine 9, no. 8: 2654.
https://doi.org/10.3390/jcm9082654
APA Style
Glatz, T., Verst, R., Kuvendjiska, J., Bronsert, P., Becker, H., Hoeppner, J., & Kulemann, B.
(2020). Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials. Journal of Clinical Medicine, 9(8), 2654.
https://doi.org/10.3390/jcm9082654
